Skip to main content
Year archive

Alteogen Inc. — 2026 filings

All 18 regulatory filings released by Alteogen Inc. (196170) in 2026, sourced directly from the official regulator.

18 Filings
2026 Period
2026 filings (18)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
투자판단관련주요경영사항 (아이젠피주(ALT-L9, 아일리아 바이오시밀러) 식약처 품목허가 승인)
Regulatory Filings
2026-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Regulatory Filings
2026-05-08 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-04-07 Korean
기업설명회(IR)개최
Investor Presentation
2026-04-07 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-31 Korean
투자판단관련주요경영사항 (재조합 인간 히알루로니다제 제품 ALT-B4 독점적 라이선스 계약 체결)
Regulatory Filings
2026-03-25 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-23 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-16 Korean
주주총회소집공고
AGM Information
2026-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2025
2026-02-27 Korean
기업설명회(IR)개최
Regulatory Filings
2026-02-20 Korean
영업(잠정)실적(공정공시)
Earnings Release FY 2025
2026-02-02 Korean
투자판단관련주요경영사항 (인간 히알루로니다제 제품(ALTB4) 독점적 라이선스 계약 체결)
Regulatory Filings
2026-01-20 Korean
기업설명회(IR)개최
Regulatory Filings
2026-01-08 Korean